companydata.dkGALECTO BIOTECH ApS: Financial statements 2024
CVR: 34878366
GALECTO BIOTECH ApS (CVR 34878366) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 5,477,168 and a net result of DKK 310,297 compared with DKK 849,392 the year before. That is a decrease of 64.1% compared with the year before. Equity amounted to DKK 8,553,704. The solvency ratio was 95.9%. The company had 36 employees in the financial year.
- Gross Profit
- 5,477,168 kr.
- Profit/Loss
- 310,297 kr.
- Equity
- 8,553,704 kr.
- Total Assets
- 8,920,077 kr.
- Employees
- 36
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 5.5 mio. | 310 t. | 8.6 mio. | 36 |
| 2023 | - | 15.3 mio. | 849 t. | 8.2 mio. | 29 |
| 2022 | - | 12.3 mio. | 819 t. | 7.4 mio. | 36 |
| 2021 | - | 9.4 mio. | 765 t. | 3.7 mio. | 29 |
| 2020 | - | 4.9 mio. | 214 t. | 2.9 mio. | 16 |
How creditworthy is GALECTO BIOTECH ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of July 31, 2024, Jonathan Paul Freve has left the board of directors of GALECTO BIOTECH ApS.
GALECTO BIOTECH ApS has published its annual report for 2023. Gross profit came to DKK 15,256,504, and the net result was DKK 849,392.
About GALECTO BIOTECH ApS
GALECTO BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Garrett Michael Winslow. The company is owned by Galecto Biotech AB. The company has 3 employees. In 2024, the company reported a gross profit of DKK 5,477,168 and a net result of DKK 310,297 compared with DKK 849,392 the year before. Equity amounted to DKK 8,553,704.